Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Debt (2021 - 2024)

Biofrontera has reported Total Debt over the past 4 years, most recently at $296000.0 for Q2 2024.

  • For Q2 2024, Total Debt changed N/A year-over-year to $296000.0; the TTM value through Jun 2024 reached $296000.0, changed N/A, while the annual FY2023 figure was $3.9 million, 43.76% down from the prior year.
  • Total Debt for Q2 2024 was $296000.0 at Biofrontera, down from $2.4 million in the prior quarter.
  • Over five years, Total Debt peaked at $7.2 million in Q3 2023 and troughed at $296000.0 in Q2 2024.
  • A 4-year average of $4.3 million and a median of $3.6 million in 2021 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: skyrocketed 122.42% in 2023 and later crashed 66.51% in 2024.
  • Year by year, Total Debt stood at $3.2 million in 2021, then surged by 114.13% to $6.9 million in 2022, then plummeted by 43.76% to $3.9 million in 2023, then plummeted by 92.42% to $296000.0 in 2024.
  • Business Quant data shows Total Debt for BFRI at $296000.0 in Q2 2024, $2.4 million in Q1 2024, and $3.9 million in Q4 2023.